Jiangsu Hengrui Medicine Co., Ltd.
600276
Κατάταξη σε μετοχές
#544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Τιμή μετοχής
$6.89
Κεφαλαιοποίηση
$43.94B
Αλλαγή (1 ημέρα)
-2.91%
Αλλαγή (1 έτος)
-24.78%
Χώρα
CN
Εμπόριο Jiangsu Hengrui Medicine Co., Ltd. (600276)
Κατηγορία
Healthcare
Δείκτης P/B για Jiangsu Hengrui Medicine Co., Ltd. (600276)
Δείκτης P/B στις October 2026 TTM: 4.71
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Jiangsu Hengrui Medicine Co., Ltd., ο τρέχων δείκτης P/B (TTM) είναι 4.71. Στο τέλος του 2024, η εταιρεία είχε P/B δείκτη 6.39.
Ιστορικό P/B για την Jiangsu Hengrui Medicine Co., Ltd. από 2001 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
| Έτος | Δείκτης P/B | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 4.71 | -25.48% |
| 2025 | 6.32 | -1.09% |
| 2024 | 6.39 | -9.65% |
| 2023 | 7.07 | 9.04% |
| 2022 | 6.49 | -29.84% |
| 2021 | 9.24 | -52.24% |
| 2020 | 19.35 | 24.50% |
| 2019 | 15.55 | 57.24% |
| 2018 | 9.89 | -5.23% |
| 2017 | 10.43 | 45.32% |
| 2016 | 7.18 | -10.85% |
| 2015 | 8.05 | 63.76% |
| 2014 | 4.92 | -13.09% |
| 2013 | 5.66 | 13.80% |
| 2012 | 4.97 | -8.81% |
| 2011 | 5.45 | -40.25% |
| 2010 | 9.12 | 4.84% |
| 2009 | 8.70 | 25.59% |
| 2008 | 6.93 | -35.14% |
| 2007 | 10.68 | 89.97% |
| 2006 | 5.62 | 451.70% |
| 2005 | 1.02 | 5.76% |
| 2004 | 0.96 | -9.87% |
| 2003 | 1.07 | -10.67% |
| 2002 | 1.20 | -6.19% |
| 2001 | 1.28 | 0.00% |
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Δείκτης P/B | Διαφορά Δείκτη P/B | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 1.3124 | -72.13% |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 7.03% |
IN
|
